Stryker is now expected to face a bribery case against Brazilian insurer Associacao Brasileira de Medicina de Grupo, also known as Abramge, in the U.S. court system, according to Reuters.
Spinal Tech
Stryker Orthopedics expanded its hip implant safety notification by recalling eight products using LFIT Anatomic CoCr V40 Femoral Heads manufactured before March 4, 2011.
Safe Orthopaedics unveiled a deal to acquire Qspine's sales force.
Medicrea received FDA clearance for its patient-specific spinal cages using its UNiD technology.
Xoran Technologies and Fiagon AG Medical Technologies agreed to expand their current collaboration to enter the neuro and spine markets.
Advertisement
The global spine surgery products market is anticipated to experience a 2.63 percent compound annual growth rate through 2022, according to BrooksInBeta.
Here are four key notes for orthopedic and spine device companies from the past week.
The global spinal cord trauma treatment market is expected to grow at a compound annual growth rate of 3.7 percent through 2027, according to a Persistent Market Research report.
Aurora Spine reported its first quarter financial results.
The spinal implant and surgical devices market is predicted to experience a 4.44 percent compound annual growth rate through 2025, according to Crystal Market Research.